Control of immune-mediated pathology via the aryl hydrocarbon receptor
暂无分享,去创建一个
[1] Shau-ku Huang,et al. Epigenetic synergism between interleukin-4 and aryl-hydrocarbon receptor in human macrophages , 2017, Journal of Molecular Medicine.
[2] Manoj Kumar,et al. INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.
[3] F. Quintana,et al. Environmental control of autoimmune inflammation in the central nervous system. , 2016, Current opinion in immunology.
[4] B. Stockinger,et al. Aryl hydrocarbon receptor is required for optimal B‐cell proliferation , 2016, The EMBO journal.
[5] H. Weiner,et al. AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice. , 2016, Cell reports.
[6] Ignacio S. Caballero,et al. Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor , 2016, Proceedings of the National Academy of Sciences.
[7] R. Gold,et al. The immunomodulatory effect of laquinimod in CNS autoimmunity is mediated by the aryl hydrocarbon receptor , 2016, Journal of Neuroimmunology.
[8] F. Sánchez‐Madrid,et al. CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis , 2016, Nature Immunology.
[9] F. Quintana,et al. Regulation of the T Cell Response by CD39. , 2016, Trends in immunology.
[10] Gonzalo Viana Di Prisco,et al. Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring , 2016, Cell.
[11] R. Xavier,et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands , 2016, Nature Medicine.
[12] J. Clemente,et al. Microbiota-driven transcriptional changes in prefrontal cortex override genetic differences in social behavior , 2016, eLife.
[13] S. Ludwin,et al. Astrocytes in multiple sclerosis , 2016, Multiple sclerosis.
[14] M. Nagarkatti,et al. Dietary Indoles Suppress Delayed-Type Hypersensitivity by Inducing a Switch from Proinflammatory Th17 Cells to Anti-Inflammatory Regulatory T Cells through Regulation of MicroRNA , 2016, The Journal of Immunology.
[15] H. Weiner,et al. Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis , 2016, Neurology: Neuroimmunology & Neuroinflammation.
[16] Bin Zhao,et al. The Aryl Hydrocarbon Receptor: A Key Bridging Molecule of External and Internal Chemical Signals. , 2015, Environmental science & technology.
[17] B. Khakh,et al. Diversity of astrocyte functions and phenotypes in neural circuits , 2015, Nature Neuroscience.
[18] I. Amit,et al. Host microbiota constantly control maturation and function of microglia in the CNS , 2015, Nature Neuroscience.
[19] C. Clish,et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α , 2015, Nature Medicine.
[20] B. Bernstein,et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation , 2015, Nature.
[21] M. Sofroniew. Astrocyte barriers to neurotoxic inflammation , 2015, Nature Reviews Neuroscience.
[22] O. Ciccarelli,et al. Exploring the origins of grey matter damage in multiple sclerosis , 2015, Nature Reviews Neuroscience.
[23] D. McTigue,et al. Chronic Oligodendrogenesis and Remyelination after Spinal Cord Injury in Mice and Rats , 2015, The Journal of Neuroscience.
[24] M. Varrin-doyer,et al. Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis , 2014, Experimental Neurology.
[25] H. Weiner,et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation , 2014, Nature Medicine.
[26] M. Geffard,et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway , 2014, Nature.
[27] M. Colonna. AHR: making the keratinocytes thick skinned. , 2014, Immunity.
[28] D. Pleasure,et al. Conditional Ablation of Astroglial CCL2 Suppresses CNS Accumulation of M1 Macrophages and Preserves Axons in Mice with MOG Peptide EAE , 2014, The Journal of Neuroscience.
[29] B. Stockinger,et al. The aryl hydrocarbon receptor: multitasking in the immune system. , 2014, Annual review of immunology.
[30] D. Arnold,et al. A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis , 2014, Journal of Neurology.
[31] R. Kontermann,et al. Astrocyte‐specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor , 2014, Glia.
[32] J. Pachter,et al. Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation , 2014, Journal of Neuroinflammation.
[33] J. Petrosino,et al. Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders , 2013, Cell.
[34] W. Brück,et al. Multiple sclerosis: Oral laquinimod for MS—bringing the brain into focus , 2013, Nature Reviews Neurology.
[35] L. Antonioli,et al. Immunity, inflammation and cancer: a leading role for adenosine , 2013, Nature Reviews Cancer.
[36] F. Quintana,et al. Aryl Hydrocarbon Receptor Control of Adaptive Immunity , 2013, Pharmacological Reviews.
[37] Dalei Wu,et al. Aryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiation , 2013, Immunology and cell biology.
[38] F. Quintana. Regulation of central nervous system autoimmunity by the aryl hydrocarbon receptor , 2013, Seminars in Immunopathology.
[39] V. Kuchroo,et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39 , 2013, Nature Immunology.
[40] T. Kishimoto,et al. Aryl hydrocarbon receptor and experimental autoimmune arthritis , 2013, Seminars in Immunopathology.
[41] A. De Luca,et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. , 2013, Immunity.
[42] S. Monti,et al. The role of the aryl hydrocarbon receptor in normal and malignant B cell development , 2013, Seminars in Immunopathology.
[43] M. Nagarkatti,et al. Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders. , 2013, Nutrition reviews.
[44] Ben A. Barres,et al. Emerging roles of astrocytes in neural circuit development , 2013, Nature Reviews Neuroscience.
[45] A. Dopazo,et al. Aryl hydrocarbon receptor contributes to the MEK/ERK-dependent maintenance of the immature state of human dendritic cells. , 2013, Blood.
[46] F. Quintana. The aryl hydrocarbon receptor: a molecular pathway for the environmental control of the immune response , 2013, Immunology.
[47] V. Shestopalov,et al. Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis , 2012, Journal of Neuroinflammation.
[48] H. Weiner,et al. Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis , 2012, Journal of Neuroimmunology.
[49] J. Seavitt,et al. Aiolos promotes TH17 differentiation by directly silencing Il2 expression , 2012, Nature Immunology.
[50] J. Palma,et al. Oral laquinimod for multiple sclerosis. , 2012, The New England journal of medicine.
[51] E. Hobeika,et al. Natural Aryl Hydrocarbon Receptor Ligands Control Organogenesis of Intestinal Lymphoid Follicles , 2011, Science.
[52] Natalie A. Roberts,et al. Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation , 2011, Cell.
[53] H. Weiner,et al. In Vivo Induction of Tr1 Cells via Mucosal Dendritic Cells and AHR Signaling , 2011, PloS one.
[54] R. Price,et al. Activation of Aryl Hydrocarbon Receptor (AhR) Leads to Reciprocal Epigenetic Regulation of FoxP3 and IL-17 Expression and Amelioration of Experimental Colitis , 2011, PloS one.
[55] C. Beyer,et al. Corticosteroids Impair Remyelination in the Corpus Callosum of Cuprizone‐Treated Mice , 2011, Journal of neuroendocrinology.
[56] Ben A. Barres,et al. Regulation of synaptic connectivity by glia , 2010, Nature.
[57] H. Weiner,et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis , 2010, Proceedings of the National Academy of Sciences.
[58] N. Wilczak,et al. Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis , 2010, Neurochemistry International.
[59] J. Fechner,et al. An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells , 2010, The Journal of Immunology.
[60] H. Weiner,et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell–like and Foxp3+ regulatory T cells , 2010, Nature Immunology.
[61] Fred H. Gage,et al. Mechanisms Underlying Inflammation in Neurodegeneration , 2010, Cell.
[62] J. Magarian Blander,et al. T helper 17 cells: discovery, function, and physiological trigger , 2010, Cellular and Molecular Life Sciences.
[63] H. Weiner,et al. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE , 2009, Nature Immunology.
[64] Michael C. Ostrowski,et al. Eos Mediates Foxp3-Dependent Gene Silencing in CD4+ Regulatory T Cells , 2009, Science.
[65] V. Kuchroo,et al. Cutting Edge: IL-27 Induces the Transcription Factor c-Maf, Cytokine IL-21, and the Costimulatory Receptor ICOS that Coordinately Act Together to Promote Differentiation of IL-10-Producing Tr1 Cells1 , 2009, The Journal of Immunology.
[66] G. Perdew,et al. Ah receptor represses acute phase response gene expression without binding to its cognate response element , 2009, Laboratory Investigation.
[67] Thomas Korn,et al. IL-17 and Th17 Cells. , 2009, Annual review of immunology.
[68] F. Virgilio,et al. Purinergic signalling in inflammation of the central nervous system , 2009, Trends in Neurosciences.
[69] M. Veldhoen,et al. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells , 2009, The Journal of experimental medicine.
[70] Guillermo Izquierdo,et al. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis , 2008, Proceedings of the National Academy of Sciences.
[71] Masahiro Yamamoto,et al. ATP drives lamina propria TH17 cell differentiation , 2008, Nature.
[72] B. Trapp,et al. Multiple sclerosis: an immune or neurodegenerative disorder? , 2008, Annual review of neuroscience.
[73] S. Miller,et al. Astrocytes in multiple sclerosis: A product of their environment , 2008, Cellular and Molecular Life Sciences.
[74] J. Buer,et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins , 2008, Nature.
[75] Terry B. Strom,et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells , 2007, Nature.
[76] F. Macian,et al. Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells. , 2007, Blood.
[77] Katharina Fleischhauer,et al. Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans , 2006, Immunological reviews.
[78] H. Weiner,et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.
[79] R. Fields,et al. Astrocytes Promote Myelination in Response to Electrical Impulses , 2006, Neuron.
[80] M. Kubo,et al. Induction and activation of the aryl hydrocarbon receptor by IL-4 in B cells. , 2005, International immunology.
[81] P. Mandal. Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology , 2005, Journal of Comparative Physiology B.
[82] M. Denison,et al. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. , 2003, Annual review of pharmacology and toxicology.
[83] A. Rebollo,et al. Ikaros, Aiolos and Helios: Transcription regulators and lymphoid malignancies , 2003, Immunology and cell biology.
[84] J. Loike,et al. Scavenger receptors in neurobiology and neuropathology: Their role on microglia and other cells of the nervous system , 2002, Glia.
[85] Richard E Peterson,et al. A ligand for the aryl hydrocarbon receptor isolated from lung , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[86] K. Georgopoulos,et al. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes , 1999, The EMBO journal.
[87] N. Kaminski,et al. Lipopolysaccharide activation of murine splenocytes and splenic B cells increased the expression of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator. , 1998, The Journal of pharmacology and experimental therapeutics.
[88] A. Puga,et al. Constitutive Activation of the Aromatic Hydrocarbon Receptor , 1998, Molecular and Cellular Biology.
[89] F. Quintana,et al. [Immunopathology of multiple sclerosis]. , 2014, Medicina.